Lexicon Pharmaceuticals Cash Flow Statement (2010-2026) | LXRX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-18.13M	-23.13M	-25.62M	-23.49M	-24.71M	-23.96M	-31.38M	-32.96M	-46.20M	-53.53M	-46.74M	-45.33M	-55.35M	-63.69M	-32.74M	-25.68M	3.74M	-12.19M	-14.78M	-1.00M
Share-based Compensation (Quarter)	2.79M	2.71M	2.23M	2.77M	2.83M	0.94M	3.27M	3.42M	2.51M	2.56M	3.21M	4.30M	1.68M	1.46M	1.54M	3.04M	1.57M	1.83M	2.83M	3.08M
Deferred Taxes (Quarter)
Gains from Investment Securities (Quarter)							-5.21M				0.82M	1.73M	-1.33M	-0.88M	0.48M	0.57M		2.63M	-1.46M	2.84M
Asset Writedowns and Impairment (Quarter)
Non-cash Items (Quarter)																		4.50M
Cash from Operations (Quarter)	-21.88M	-17.15M	-22.83M	-23.42M	-24.42M	-19.44M	-21.57M	-31.61M	-38.12M	-41.62M	-50.55M	-55.13M	-48.54M	-53.62M	-21.49M	-43.78M	16.99M	-23.83M	-17.23M	-14.73M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)											2.00M	1.40M	3.31M	2.71M	1.89M	1.33M	1.21M	0.73M	0.44M	0.56M
Amortization of Deferred Charges (Quarter)	0.01M	0.02M	0.01M	0.03M	0.15M	0.22M	0.34M	0.27M	0.27M	0.62M	0.62M	0.52M	0.53M	0.40M	0.40M	0.40M	0.40M	0.40M	0.49M	0.68M
Depreciation & Amortization (CF) (Quarter)	0.04M	0.10M	0.11M	0.11M	0.11M	0.11M	0.10M	0.11M	0.14M	0.15M	0.15M	0.14M	0.14M	0.13M	0.12M	0.18M	0.18M	0.15M	0.12M	0.11M
Change in Working Capital
Change in Receivables (Quarter)	0.06M	-0.14M	-0.01M	0.02M	-0.00M	0.01M	-0.01M	0.23M	0.42M	-0.37M	0.69M	0.52M	1.09M	0.28M	0.58M	-1.03M	-0.26M	0.15M	0.05M	9.39M
Change in Inventory (Quarter)									0.17M	0.16M	0.04M	0.13M	0.07M	0.05M	-0.41M	-0.03M	-0.03M	-0.01M	0.12M	-0.01M
Change in Accured Expenses (Quarter)	-6.29M	1.27M	-0.72M	-3.31M	-2.14M	0.81M	4.71M	-2.77M	5.76M	6.11M	-2.65M	-9.11M	5.91M	8.87M	9.13M	-21.69M	11.12M	-14.00M	-5.65M	-6.90M
Other Working Capital Changes (Quarter)	0.64M	-0.01M	-2.43M	-0.21M	0.94M	-0.26M	-0.15M	0.87M	2.78M	-1.71M	0.96M	-0.17M	2.71M	-3.06M	-0.64M	-1.21M	0.84M	-0.19M	-0.96M	-0.20M
Investing Activities
Capital Expenditures (Quarter)	0.95M	0.21M	0.02M	0.08M		0.00M	1.25M	0.25M	0.14M	0.08M			0.25M	0.31M	0.47M
Sales of Property, Plant and Equipment (Quarter)
Change in Acquisitions & Divestments (Quarter)	17.77M	4.32M	11.50M	13.48M	8.71M	16.00M	26.01M	41.20M	47.66M	33.00M	52.00M	73.00M	65.00M	96.40M	80.00M	105.55M	41.45M	78.85M	27.00M	35.70M
Cash from Investing Activities (Quarter)	14.14M	-0.40M	6.10M	-4.41M	-13.65M	-77.20M	24.17M	12.09M	-74.61M	-39.33M	51.90M	-110.22M	-12.32M	53.47M	53.70M	40.58M	15.48M	52.12M	4.83M	-70.26M
Financing Activities
Other financing activities (Quarter)												-0.40M		-0.91M	-0.00M
Cash from Financing Activities (Quarter)	-0.02M	19.78M	-11.32M	23.28M		94.02M	24.91M	-0.82M	189.00M	-0.21M	-0.00M	239.38M	-0.01M	-0.92M	-0.10M	-0.57M	-45.00M		-2.93M	88.76M
Additional items
Change in Cash (Quarter)	-7.76M	2.23M	-28.05M	-4.54M	-38.07M	-2.62M	27.51M	-20.34M	76.27M	-81.16M	1.35M	74.03M	-60.88M	-1.07M	32.10M	-3.77M	-12.52M	28.29M	-15.33M	3.76M
Free Cash Flow (Quarter)	-22.83M	-17.36M	-22.85M	-23.50M	-24.42M	-19.44M	-22.82M	-31.86M	-38.26M	-41.70M	-50.55M	-55.13M	-48.79M	-53.93M	-21.96M	-43.78M	16.99M	-23.83M	-17.23M	-14.73M
Net Cash Flow (Quarter)	-7.76M	2.23M	-28.05M	-4.54M	-38.07M	-2.62M	27.51M	-20.34M	76.27M	-81.16M	1.35M	74.03M	-60.88M	-1.07M	32.10M	-3.77M	-12.52M	28.29M	-15.33M	3.76M

Research Tools

Developers

Lexicon Pharmaceuticals Cash Flow Statement (2010-2026) | LXRX

Research Tools

Developers

Lexicon Pharmaceuticals Cash Flow Statement (2010-2026) | LXRX

Create an account

Sign In

Reset Password